Department of Psychiatry, University of California, San Francisco, San Francisco, CA 94110, USA.
Psychiatr Serv. 2013 Jun;64(6):597-9. doi: 10.1176/appi.ps.002542012.
The purpose of this study was to evaluate attitudes of primary care providers toward barriers to metabolic monitoring and to characterize their beliefs about providers' responsibility for monitoring and reducing cardiovascular risk for people with severe mental illness.
An anonymous survey was administered to 214 primary care providers working in 23 public community health clinics in San Francisco.
The response rate was 77% (164 of 214). Nearly 40% of primary care providers were unaware of consensus guidelines for metabolic monitoring of people who take second-generation antipsychotic medications. Responses showed variation in providers' beliefs about who should monitor patients' metabolic risk. The major barriers to metabolic monitoring were severity of psychiatric illness, difficulty collaborating with psychiatrists, and difficulty arranging psychiatric follow-up.
Primary care providers believed that better communication between primary care providers and psychiatrists would facilitate metabolic monitoring and promote better treatment for patients with severe mental illness who are taking antipsychotic medications.
本研究旨在评估初级保健提供者对代谢监测障碍的态度,并描述他们对提供者监测和降低严重精神疾病患者心血管风险的责任的看法。
对在旧金山 23 家公共社区卫生诊所工作的 214 名初级保健提供者进行了匿名调查。
响应率为 77%(214 名中的 164 名)。近 40%的初级保健提供者不知道对服用第二代抗精神病药物的人进行代谢监测的共识指南。调查结果显示,提供者对谁应该监测患者的代谢风险的看法存在差异。代谢监测的主要障碍是精神疾病的严重程度、与精神科医生合作的难度以及安排精神科随访的难度。
初级保健提供者认为,初级保健提供者和精神科医生之间更好的沟通将促进代谢监测,并为服用抗精神病药物的严重精神疾病患者提供更好的治疗。